期刊文献+

淫羊藿总黄酮胶囊中黄酮类成分含量测定及抗骨质疏松活性研究 被引量:23

Determination of flavonoids constituents in epimedium total flavone capsule and research on its anti-osteoporosis activity
原文传递
导出
摘要 采用快速液相色谱法(RRLC)对淫羊藿总黄酮胶囊进行含量测定,建立了淫羊藿新苷A、朝霍定A1、朝霍定A、朝霍定B、朝霍定C、淫羊藿苷、宝藿苷Ⅱ、淫羊藿次苷Ⅰ、箭藿苷B、鼠李糖基淫羊藿次苷Ⅱ、宝藿苷Ⅰ等11个黄酮类成分的含量测定方法。同时,通过检测碱性磷酸酶(AKP)含量,考察了11个化合物诱导MC3T3-E1细胞增殖分化的效果,结果显示宝藿苷Ⅱ活性最好,宝藿苷Ⅱ和淫羊藿次苷Ⅰ活性都大于淫羊藿苷。该研究建立了黄酮苷类成分的含量测定方法,并比较了每个单体抗骨质疏松的效果,为淫羊藿总黄酮胶囊药效物质基础和作用机制研究提供了技术支持。 To develop a rapid resolution liquid chromatography(RRLC) method for the simultaneous determination of epimedoside A,epimedin A1,epimedin A,epimedin B,epimedin C,icariin,baohuosideⅡ,icarisideⅠ,sagittatoside B,2″-O-rhamnosyl icarisideⅡ,and baohuosideⅠin epimedium total flavone capsule. At the same time,the effects of the above 11 compounds on osteogenic differentiation of MC3 T3-E1 cells were investigated by detecting the content of alkaline phosphatase(AKP). The results showed that baohuoside Ⅱ had the highest activities,and both the activities of baohuoside Ⅱ and icariside Ⅰ were stronger than those of icariin.In this study,the content determination method of flavonoid glycosides was established,and the anti-osteoporosis effect of monomers was compared,providing technical support for the study of the pharmacodynamic and mechanism of Epimedium total flavone capsule.
作者 徐忠坤 殷洪梅 李芳 秦建平 顾少莉 吴云 王振中 萧伟 XU Zhong-kun;YIN Hong-mei;LI Fang;QIN Jian-ping;GU Shao-li;WU Yun;WANG Zhen-zhong;XIAO Wei(Jiangsu Kanion Pharmaceutical Co.,Ltd.,Lianyungang 222001,China;State Key Laboratory of Pharmaceutical Process New-tech for Chinese Medicine,Lianyungang 222001,China;Key Laboratory for the New Technique Research of Traditional Chinese Medicine Extraction and Purification,Lianyungang 222001,China)
出处 《中国中药杂志》 CAS CSCD 北大核心 2018年第15期3140-3144,共5页 China Journal of Chinese Materia Medica
基金 国家“重大新药创制”科技重大专项(2013ZX09402203)
关键词 淫羊藿总黄酮胶囊 黄酮苷 RRLC MC3T3-E1 AKP epimedium total flavone capsule flavonoid glycoside RRLC MC3TB-EI AKP
  • 相关文献

参考文献12

二级参考文献107

共引文献162

同被引文献387

引证文献23

二级引证文献213

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部